Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Huffnagle (Ann Arbour, United States of America). The consequences of microbiome and pathogen dynamics for chronic lung diseases. Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation

Member's Comments

No comment yet.

Related content which might interest you: The microbiome in chronic respiratory diseases Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice? Year: 2017 Interplay between bacterial infections, hypoxia and the development of chronic lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Targeting the microbiome in respiratory diseases Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 The microbiome and childhood respiratory diseases Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 The lung microbiome and its effects on respiratory infections Source: Virtual Congress 2020 – Respiratory infections Year: 2020 Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019 Year: 2020 Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 The consequence of matrix dysfunction on lung immunity and the microbiome in COPD Source: Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018 Year: 2018 Host–microbe interactions in distal airways: relevance to chronic airway diseases Source: Eur Respir Rev 2015; 24: 78-91 Year: 2015 The role of chronic infection in respiratory diseases Source: International Congress 2018 – Chinese Programme 2018: Part I Year: 2018 Manipulating the microbiome to control human diseases Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs Year: 2018 Post-viral effects on the susceptibility of developing chronic lung diseases Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 Early interventions with bacterial metabolites to prevent the development of chronic lung diseases Source: International Congress 2018 – Cross-talk in the lung microenvironment: implications for chronic lung disease Year: 2018 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing Source: Eur Respir J 2014; 44: 1682-1696 Year: 2014 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 From culturomics to metagenomics: the mycobiome in chronic respiratory diseases Source: Eur Respir Monogr 2019; 83: 88-118 Year: 2019